Background
Appeals have been made for eye care professionals to start prescribing anti-myopia therapies as part of their routine management of myopic children [1] [2] [3] . These calls are fuelled by two key considerations.
Firstly, that interventions to slow myopia progression have shown success in randomized controlled trials (RCTs) [4] [5] [6] [7] , and secondly, appreciation that the risk of sight-threatening complications rises dosedependently with the level of myopia 8, 9 . Notwithstanding existing gaps in knowledge regarding the efficacy of current treatments (see below), these considerations argue that myopia control interventions should be widely adopted, and that they should be instigated at an early age -especially in children most at risk -in order to reduce the final level of myopia. Therefore in managing a child with myopia, an eye care professional would have to decide not only which therapy to recommend, but at what age to start treatment. In this review we discuss the future role of genetic prediction in helping clinicians treat myopia.
When might genetic prediction be useful?
We envisage three situations when genetic prediction might be helpful to clinicians; the personalized medicine s e a io, the prophylactic intervention s e a io, a d the prevention of high myopia scenario.
While the average response to the best anti-myopia therapy reported is approximately 40-50%, there is typically a wide variability in response between patients 5, 7 . If a child's genetic profile makes them a better responder to one type of therapy compared to another, e.g. orthokeratology vs. atropine, then clinicians could tailor treatments to individual patients who would benefit the most. This concept of personalized medicine has been around for a long time outside the field of myopia yet has only recently started to make a difference to clinical practice -most notably in cancer care 10 . To date there is no research evidence supporting the use of genetic testing in choosing the most suitable anti-myopia therapy for an individual child, but one study has shown how a specific myopia risk allele and a specific environmental risk factor (time spent reading) can interact to markedly elevate susceptibility 11 , hinting that the personalized medicine approach may have merit. A comprehensive evidence base for personalizing anti-myopia therapy is unlikely to be forthcoming in the short to medium term because to achieve the necessary statistical power such studies would need to enrol thousands of patients and, ideally, follow highly standardized treatment protocols. If future intervention trials routinely genotyped subjects, then such data could be derived through individual patient meta-analysis.
What is the case for prophylactic intervention? Here again there is a lack of research evidence showing that the currently-available treatment options work when initiated prior to myopia onset -with the single exception of increased time outdoors, which has been shown in 2 rigorous, RCTs to reduce incident myopia by a clinically significant degree 12, 13 . So should eye care professionals e p es i i g more time outdoors to children at high risk of developing myopia? Any benefit of genetic prediction for such a simple intervention appears minimal; after all, spending more time outdoors provides health benefits for a child beyond refractive development and poses minimal adverse effects (if the dangers of excessive sun exposure are mitigated by recommending that children wear appropriate sunglasses, sun cream, and a hat). This argues that prescribing extra time outdoors should be done routinely, though in the real world, prescribing extra time outdoors may not work as effectively as other possible interventions, since spending the (currently unknown) necessary number of hours outdoors every day a ot fit ith a fa ilies' lifest les. However, knowing that a child has a high genetic predisposition to myopia might give parents an extra incentive to increase their child's ti e outdoors.
Ultimately such interventions are likely to be worthwhile if they result in a lower degree of myopia, but final refraction was not significantly altered in the largest randomized trial to date of additional outdoor time 12 .
The two types of intervention that have shown the most impact on myopia progression so far are pharmacological (atropine at various doses) and optical (multifocal contact lenses and orthokeratology) approaches [4] [5] [6] [7] . Is genetic prediction any better than prediction based on existing known risk factors?
Researchers from the CLEERE study group 15 recently evaluated which risk factors were most useful in predicting children at-risk of incident myopia, using data from a large, multi-centre longitudinal study of U.S. children. They considered 13 potential predictive factors, including spherical equivalent refractive error at baseline and parentally-reported number of myopic parents. Spherical equivalent at baseline was the single best predictive factor, and indeed this predictive factor alone performed as well, essentially, as any other combination of predictive factors. Notably, parental myopia (i.e. having 0, 1 or 2 myopic parents) was not a useful predictor once spherical equivalent refractive error at baseline was known. A predictive model for incident myopia using current refractive error and parental myopia as risk factors performed with a sensitivity and specificity of 62.5% and 81.9% in CLEERE participants 16 .
At fi st gla e the CLEERE stud 's fi di gs 15 would seem to imply that genetic prediction is probably not worth the trouble, as it would offer no benefit over-and-above measuring cycloplegic refractive error in early childhood. However, there are 3 reasons to expect that -at least in theory -genetic prediction will be a better predictive factor for myopia than number of myopic parents. Firstly, for a highly polygenic trait such as refractive error, parental myopia is only a good predictor of the refractive error of the pa e ts' children on average, not the refractive error of any individual child. Secondly, parental myopia uses a bina s ale, hi h ea s that pa e ts' a tual le els of opia a e ig o ed in the predictive modelling process. Thirdly, parental myopia is not well suited to predicting the future severity of refractive error in an individual, which means that the risk of future pathological complications will remain uncertain. While this limitation could be mitigated by predicting the risk of high myopia rather than myopia, there would still be benefits to knowing whether an individual was likely to attain a refractive error in adulthood of, for example, -6.50 D or -20.00 D.
To illustrate the first point mentioned above, Figure 1 shows the relationship between the refractive error of parents and their children using computer simulations performed under the assumption that refractive error is a purely polygenic trait (details of the simulation parameters are available from the authors on request). For heritability values across the range 25% to 75%, which is typical of the range reported for refractive error and myopia [17] [18] [19] , it is evident that while the mean refractive error of parents is a good predictor of the average refractive error of their children (blue line of best fit in the graphs) it is only a crude guide to the refractive error of individual children. To illustrate the second point mentioned above, we generated simulations of a larger sample of 2-parent-plus-1-child families and evaluated the efficacy of 3 different predictive factors: (a) number of myopic parents, (b) the average refractive error of the pa e ts alled the idpa e t alue i the ge eti s lite atu e , a d the precise genetic risk of the child. The results are shown in Figures 2 and 3 . It is apparent that the loss of information inherent when simply counting the number of myopic parents adversely impacts the ability to predict the refractive error of children -at least under the conditions used in the computer simulation. However, it is also clear that perfect genetic prediction is a very much better predictive factor than the midparent value, capturing essentially all of the available variability (as governed in the simulation by the level of heritability). In reality it is not possible to predict the genetic risk of an individual with 100% precision, and in this sense the results of genetic prediction shown in Figure 2 are misleading. However, as we discuss further below, they do offer a glimpse of what genetic prediction has to offer.
How effective is the genetic prediction of refractive error currently?
Very few studies have tested the current efficacy of genetic prediction for refractive error. In those that have, the variance in refractive error explained -i.e. the coefficient of determination (r 2 value) from a linear regression of t ue ef a ti e e o (y-axis) on p edi ted ef a ti e e o (x-axis) -was used as the measure of predictive performance. R 2 values are well-suited to quantifying the efficacy of continuous traits compared to statistics such as the positive/negative predictive value or area under the receiver-operating curve (AUC) commonly used for classifying individuals as either affected or unaffected by a disorder 20 . The CREAM consortium 21 identified 26 genetic variants associated with refractive error in a genome-wide association study (GWAS) and epo ted that a polygenic risk score (PGRS) comprised of these variants explained 3.4% of the phenotypic variation in refractive error. Fan et al. 22 used a simpler approach -a allele s o e al ulated ou ti g the u e of high isk alleles carried by individuals for 39 genetic variants identified from the GWAS studies of the CREAM consortium 21 and Kiefer et al.
23
-and were able to explain 2.3% of the variation in refractive error for a sample of 15-year old children. Thus, using a PGRS or allele score comprised of the small numbers of ge eti a ia ts that eet the e t e el st i ge t th eshold of ge o e-ide sig ifi a e i a current GWAS provides poor predictive performance (r 2 <0.05).
As shown in Figure 4 , the performance of a genetic prediction algorithm varies primarily depending on Refraction is the end result of a complex growth process 25 , and the value of GWAS data may be enhanced by asking more specific questions related to different aspects of refractive development.
Evaluating genetic associations with factors known to be associated with higher rates of final myopia (i.e. age of onset, initial rate of progression and duration of progression), or looking for genetic associations with a final axial length in excess of 26 mm may further enhance the genetic predictability of final refraction.
How effective will genetic prediction of refractive error be in the future? Figure 4 gives an indication of the prospects for genetic prediction of refractive error in the future. As GWAS meta-analysis sample sizes approach 500,000 -1,000,000 it should be possible to estimate the parameters in a PGRS or an equivalent Bayesian model with sufficient precision that prediction accuracy ). An important caveat here, however, is that prediction accuracy is likely to be populationspecific, like heritability estimates themselves. Thus, prediction accuracy would be expected to be worse when a prediction model is developed and tested in individuals of differing ancestry 26 . For refractive error prediction this could be highly disadvantageous, since most large GWAS analyses are carried out in individuals of European ancestry (due to high investment in population-based genetics research in Europe and the United States) whereas the most urgent need for genetic prediction of myopia is in South-East Asia 27 . It may also be the case that genetic prediction may be suboptimal when the prediction model is developed and tested in individuals born in differing generations. Suppose one generation grew up in an environment with limited exposure to environmental risk factors for myopia, whereas for a younger generation these risk factors had become pervasive, then major influences from gene-environment interactions could impair genetic prediction models 28 .
What about the environment?
The extent to which genetic risk factors for myopia are deterministic, i.e. act independently of environmental exposures such as near work, education or time outdoors, is largely unknown. To date, just a handful of genetic variants have been reported to confer a greater risk in children who spend relatively more time than average engaged in near work or in full-time education (and of these, only one such gene-environment interaction has been replicated) 11, 22, 29, 30 . No gene-environment (G x E) interactions involving time outdoors have been discovered. If G x E interactions turn out to be commonplace, then genetic predictions might benefit from taking lifestyle factors into account, e.g.
given a particular hild's ge eti p ofile, their risk may be different if they leave full-time education at age 18 compared to if they go on to University. This could improve the accuracy of genetic prediction above the likely h 2 SNP-based limit of approximately 35%, at the expense of a parents being given a more complicated message a out thei hild's isk of opia.
Some of the effects of the environment and some G x E interactions affecting refractive development are likely to operate via epigenetics, i.e. modifications to the chemical nature of specific regions of the genome that alter gene expression patterns without changing the genome sequence. No such epigenetic changes with effects on myopia are known currently, and, at least according to theory, the utility of epigenetics for genetic prediction is likely to be low, since the changes in chemistry and gene expression may be restricted to particular ocular tissues, making them unavailable for analysis (in marked contrast to the readily-captured and decoded genome sequence).
The research literature currently suggests that for levels of time reading and time outdoors within the normal range, spending more time outdoors or less time on near work than average has limited impact on refractive error (e.g. time reading and time outdoors ascertained at age 8 years-old together explained <2% of the variation in refractive error at age 15 years-old 24 ). Therefore unless future research finds that spending much greater time outdoors than is commonly the case has a far larger benefit than this, then augmenting genetic predictions with pure (non-GxE) lifestyle-related risks will not be worthwhile 15 . In contrast, there may be benefits in combining genetic risk scores with information about parental myopia, under the assumption that myopic parents pass on not only their genes, but also their relatively myopiagenic environment to their children. As a precedent for this approach, a recent study 31 suggested the genetic risk for heart disease was independent of self-reported family history, making a strong case for combining these sources of information. suffering from a likely genetic disease). The main obstacles arguing against routine genetic testing were deemed to be (i) the limited precision of current tests for the majority of diseases and disorders, (ii) a lack of evidence about how probabilistic information is best communicated to parents and children, and (iii) issues surrounding stigma and discrimination. Research aiming to address these issues is currently on-going, for instance, evaluating the pros and cons of using genome sequencing to diagnose the cause of intellectual disability, and how best to communicate this information to parents and those affected 33 .
Questions for society
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Some individuals have taken steps to investigate their risk of genetic disorders themselves. For instance, the consumer genetics testing company 23andMe provided its one millionth customer with genetic predictions for a range of disorders, in 2015. (Most of these customers are from the United States, and paid around US$100 for the test) 34 . Questions surrounding the use, and possible misuse, of genetic testing are important topics for debate that will become ever more important as prediction accuracy continues to improve.
Unanswered Clinical Questions
Although good evidence exists for the short term effectiveness of interventions to slow myopia progression, such approaches are not in routine use. Alongside developing predictive tests to help decide who might benefit from treatment, it is important to recognise that many treatment-related
questions have yet to be addressed. These include the long term safety of pharmacological treatments, risks of keratitis in contact lens treatment modalities in young children, appropriate duration of treatment, decreased efficacy of treatments when used over several years, optimal age of treatment, and the potential for later rebound effects. Due to the time delay of many years between myopia onset and the manifestation of myopia-related ocular pathologies (cataract, glaucoma, retinal detachment and myopic maculopathy), the most challenging evidence to collect will be the impact of reduction in myopia progression on such ocular pathology in later life.
Concluding remarks
In the longer term, genetic prediction has the potential to enhance the detection of children who would benefit from treatment to slow, or ideally prevent, myopia progression. Based on current knowledge of the aetiology of refractive error, genetic prediction has the potential to perform better than existing methods (the best of which -using baseline refractive error and number of myopic parents as predictors -has a sensitivity and specificity of 62.5% and 81.9%). Compared to the use of baseline refractive error as a predictor, genetic prediction has the advantages that it can be employed at a very young age and does not rely on cooperation by the child being tested. Therefore, it is likely to be most effective when employed prior to the development of myopia -although, at present there is no research evidence supporting the prophylactic use of anti-myopia interventions other than time outdoors. Current genetic prediction models perform very poorly (explaining <5% of the variance in refractive error). To reach their full potential -explaining up to approximately 35% of the variance in refractive error -will require genetic prediction models to leverage information from GWAS involving 10-20 times larger sample sizes than those performed to date, carried out in participants with a range of ancestries/ethnicities.
Incorporating the collection of information on genetic and other identifiable risk factors into the design of future myopia interventions trials will maximise the prospects for predicting myopia. Computer simulations were carried out assuming a purely polygenic mode of inheritance for refractive error, at three different levels of heritability (25%, 50% and 75%). The refractive error of children is plotted as a function of either: (a) the number of myopic parents, (b) the average refractive error of the parents, or (c) the genetic risk of the child evaluated assuming perfect precision. For each graph the line of best fit is shown in blue and the r-squared value quantifies predictive efficacy (how much of the a iatio i hild e 's ef a ti e e o a e e plai ed the p edi ti e fa to . 20 at different heritability levels.
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